ImmunoCellular Therapeutics (IMUC) Trims Number of Shares in Expected Stock Offering

August 8, 2016 7:28 AM EDT

News and research before you hear about it on CNBC and others. Claim your 2-week free trial to StreetInsider Premium here.

ImmunoCellular Therapeutics (NYSE: IMUC) filed Post-Effective Amendment No. 1 to its Registration Statement on Form S-1. In part, the filing said that the company plans to sell 45 million shares of its common stock, down from 51.5 million shares prior.

Serious News for Serious Traders! Try Premium Free!

You May Also Be Interested In

Related Categories

Corporate News, Equity Offerings

Related Entities


Add Your Comment